Smitha Mallaiah

Mrs. Smitha Mallaiah

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 December 2022 in Integrative Cancer Therapies
Verified
Journal Article
Open access
SMSmitha Mallaiah
Smitha Mallaiah
SNSanthosshi Narayanan
Santhosshi Narayanan
RWRichard Wagner
Richard Wagner
CCChiara Cohen
Chiara Cohen
ACAimee J. Christie
Aimee J. Christie
LCLorenzo Cohen
Lorenzo Cohen
Background: Yoga is an evidence-based mind-body practice known to improve physical and mental health in cancer patients. We report on the processes and patient-reported outcomes of one-on-one yoga therapy (YT) consultations delivered via telehealth. Methods: For patients completing a YT consultation between March 2020 and October 2021, we examined demographics, reasons for referral, and self-reported symptom burden before and after one YT session using the Edmonton Symptom Assessment Scale (ESAS). Changes in ESAS symptom and subscale scores [physical distress (PHS), psychological distress (PSS), and global distress (GDS)] were evaluated by Wilcoxon signed-rank test. Descriptive statistics summarized the data. Results: Ninety-seven initial YT consults were completed, with data evaluated for 95 patient encounters. The majority were women (83.2%) and white (75.8%), The mean age for females was 54.0 and for males was 53.4; the most common diagnosis was breast cancer (48%), 32.6% had metastatic disease, and nearly half (48.4%) were employed full-time. Mental health (43.0%) was the most common reason for referral, followed by fatigue (13.2%) and sleep disturbances (11.7%). The highest symptoms at baseline were sleep disturbance (4.3), followed by anxiety (3.7) and fatigue (3.5). YT lead to clinically and statistically significant reductions in PHS (mean change = −3.1, P < .001) and GDS (mean change = −5.1, P < .001) and significant reductions in PSS (mean change = −1.6, P < .001). Examination of specific symptom scores revealed clinically and statistically significant reductions in anxiety (mean change score −1.34, P < .001) and fatigue (mean change score −1.22, P < .001). Exploratory analyses of patients scoring ≥1 for specific symptoms pre-YT revealed clinically and statistically significant improvements in almost all symptoms and those scoring ≥4 pre-YT. Conclusions: As part of an integrative oncology outpatient consultation service, a single YT intervention delivered via telehealth contributed to a significant improvement in global, physical, and psychosocial distress. Additional research is warranted to explore the long-term sustainability of the improvement in symptoms.

5 March 2024 in Journal of Pain and Symptom Management
Verified
Journal Article
Closed access
KMKathrin Milbury
Kathrin Milbury
DRDavid I. Rosenthal
David I. Rosenthal
YLYisheng Li
Yisheng Li
ANAn Ngo-Huang
An Ngo-Huang
SMSmitha Mallaiah
Smitha Mallaiah
LCLorenzo Cohen
Lorenzo Cohen

11 December 2025 in Supportive Care in Cancer
Verified
Journal Article
Closed access
PDF file
SMSmitha Mallaiah
Smitha Mallaiah
LRLois Ramondetta
Lois Ramondetta
MMMeroë Morse
Meroë Morse
SNSanthosshi Narayanan
Santhosshi Narayanan
JRJillian Rigert
Jillian Rigert
LCLorenzo Cohen
Lorenzo Cohen

1 April 2026 in Global Advances in Integrative Medicine and Health
Verified
Journal Article
Open access
SMSmitha Mallaiah
Smitha Mallaiah
AOAmanda Olson
Amanda Olson
MDMay Daher
May Daher
SMScherezade K. Mama
Scherezade K. Mama
SNSanthosshi Narayanan
Santhosshi Narayanan
LCLorenzo Cohen
Lorenzo Cohen
Background: Cancer is a global health challenge that continues to rise worldwide. People with cancer in low- and middle-income countries (LMIC) have less access to integrative oncology programs than their counterparts in high-income countries. This is especially true of countries on the African continent, such as Tanzania. LMICs have a disproportionately higher cancer burden than their counterparts. Hematopoietic Stem Cell Transplantation (HSCT) requires extended hospitalization, including social isolation. While yoga is often recommended to help manage symptoms in oncology patients, its use has not been systematically evaluated among hospitalized patients or those undergoing HSCT. To address this gap, we designed a pilot study to culturally tailor and implement a yoga program for HSCT inpatients across diverse settings in Tanzania, India, and the United States. Methods: Five patients with hematological malignancy who underwent HSCT within the past year from each of the 3 centers will participate in semi-structured interviews to explore cultural norms, culturally appropriate language, and factors specific to yoga and psychosocial support. After any modifications to the program, 15 patients from each center will participate in the yoga program 2 weeks before HSCT and for the first 30 days after HSCT via in-person, telehealth (Zoom), or in combination. We will declare the intervention feasible if (a) at least 50% of patients complete a minimum of 6 of the 12 YT sessions and (b) at least 60% of patients complete follow-up measures at 2 months after transplant. Conclusion: This trial will provide important information regarding the cultural sensitivity and feasibility of an inpatient yoga program provided during hospitalization for 3 different centers. This data is necessary before embarking on a multicenter randomized clinical trial.

1 March 2026 in JCO Global Oncology
Verified
Journal Article
Open access
SMSmitha Mallaiah
Smitha Mallaiah
VMVijaya Majumdar
Vijaya Majumdar
SMScherezade K. Mama
Scherezade K. Mama
AOAmanda L. Olson
Amanda L. Olson
MDMay Daher
May Daher
LCLorenzo Cohen
Lorenzo Cohen
PURPOSE: Yoga therapy (YT) is a growing mind-body approach in oncology. However, its integration into hematopoietic stem cell transplantation (HSCT) remains limited, particularly in non-Western and resource-constrained settings. This formative qualitative study aimed to explore the lived experiences of HSCT patients in the United States, India, and Tanzania to inform the development of a culturally adapted YT protocol. METHODS: Fifteen post-HSCT adult participants were recruited from three international cancer centers using purposive sampling. Semistructured interviews were conducted in participants' preferred languages, transcribed, and thematically analyzed by an interdisciplinary team. Themes were mapped to domains of the Adaptome framework to guide adaptation decisions. RESULTS: Across sites, fatigue, sleep disruption, isolation, and emotional distress were common. Participants expressed interest in supportive, noninvasive interventions like yoga, but familiarity varied by region. Cultural adaptations included neutral, nonreligious language for meditation, flexible session timing, caregiver inclusion, same-language preference, and same-sex therapist. Contextual adaptations addressed environmental limitations (eg, space constraints, infection precautions), such as bed- and chair-based modules. Participants recommended short (20-30-minute), afternoon sessions with hybrid delivery options. Trust in the person introducing yoga (eg, physician v therapist) emerged as a culturally relevant factor. CONCLUSION: This formative study offers critical insights into adapting (YT) for patients undergoing HSCT across diverse global contexts. Using the Adaptome framework, we applied a systematic, culturally, and contextually responsive approach that preserved core therapeutic elements while enhancing feasibility and relevance. These evidence-based adaptations directly informed the design and implementation of a single-arm, phase II trial of adjunct yoga in HSCT patients.

27 May 2026 in Cancers
Verified
Journal Article
Open access
PDF file
CPCatherine Powers-James
Catherine Powers-James
ACAimee J Christie
Aimee J Christie
BABanu K. Arun
Banu K. Arun
TATaylor Austin-Isbell
Taylor Austin-Isbell
GBGildy Babiera
Gildy Babiera
LCLorenzo Cohen
Lorenzo Cohen
Importance: Lifestyle and supportive care interventions may improve treatment tolerance, long-term health behaviors, and survivorship outcomes among breast cancer patients receiving radiotherapy. Few randomized trials have integrated nutrition, exercise, stress management, and psychosocial counseling concurrently with radiotherapy and extended across survivorship. Objective: To evaluate the effects of a comprehensive lifestyle intervention (CompLife) initiated during radiotherapy and maintained for 12 months on body composition, fitness, quality of life, symptoms, and nutrition. Design, Setting, and Participants: Randomized clinical trial at a single cancer center. Eligible women were aged ≥18 years with stage II/III breast cancer scheduled for radiotherapy, BMI ≥ 24.5, and ≥2 lifestyle risk factors. Participants were randomized to CompLife or standard of care (SOC). Assessments occurred at baseline, end of radiotherapy, and 3, 6, and 12 months. The primary outcome of recurrence is ongoing; this report examines prespecified secondary outcomes. Interventions: CompLife included 6 weeks of in-person counseling integrating nutrition, physical activity, mindfulness, stress management, and psychosocial support; twice-weekly exercise, diet, and mind–body sessions during radiotherapy; and telehealth counseling for 12 months. SOC participants received standard educational materials. Main Outcomes and Measures: Secondary outcomes included visceral adipose tissue (VAT), weight, waist circumference, fitness (VO2 max, strength), SF-36 Physical and Mental Component Summary scores, MD Anderson Symptom Inventory scores, mindfulness (FFMQ), and dietary fiber intake. Results: Ninety-five women were randomized (CompLife, n = 50; SOC, n = 45). CompLife participants had lower VAT at 3 and 6 months (e.g., 3 months: 118 vs. 141 cm2; p = 0.044) and greater improvements in VO2 max at 3 (23.4 vs. 18.8 mL/kg/min; p = 0.025) and 6 months. SF-36 Physical scores improved to within population norms for CompLife at all follow-ups but remained below norms in SOC. CompLife participants reported fewer symptoms at 12 months (MDASI: 1.3 vs. 2.5; p = 0.014). Fiber intake was consistently higher in CompLife participants (20.5 g vs. 14.0 g; p < 0.001). The results should be interpreted with caution due to the large number of comparisons among the secondary outcomes. Conclusions and Relevance: A multidisciplinary lifestyle intervention delivered during radiotherapy and extended across survivorship produced clinically meaningful improvements in body composition, fitness, diet, and patient-reported outcomes. The findings suggest potential value in integrating structured lifestyle and psychosocial counseling into oncology care and warrant confirmation in larger multicenter trials with mature recurrence endpoints.